Front Page News

Community Spotlight: Braedon’s Newborn Screening Diagnosis

September 8, 2020
Posted in ,

September is Newborn Screening Awareness Month, a chance to talk about the progress we have made in getting spinal muscular atrophy (SMA) added to newborn […]

Read More ›

Biogen Q3 2020 Community Statement: COVID-19 Updates and Latest Milestones

August 27, 2020
Posted in ,

Dear Members of the SMA Community, We continue to work with the healthcare community to help people and families living with SMA get the support […]

Read More ›

Scholar Rock Announces that SRK-015 has Received Rare Pediatric Disease Designation from U.S. FDA for the Treatment of SMA

August 14, 2020
Posted in ,

Scholar Rock, a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that […]

Read More ›

Genentech Releases Evrysdi™ FDA Approval Letter to the SMA Community

August 11, 2020
Posted in ,

Dear SMA Patient Advocacy Community, As part of our ongoing partnership and following your request to receive updates about the risdiplam clinical development program, we […]

Read More ›

Genentech Receives FDA Approval of Evrysdi (risdiplam) for the Treatment of SMA

August 7, 2020
Posted in ,

Genentech, a member of the Roche Group, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Evrysdi (risdiplam) to treat adults […]

Read More ›

Cure SMA Launches New Medical Alert Bracelet Support Program

July 29, 2020
Posted in ,

Along with funding SMA research and care, Cure SMA provides thousands of individuals and families with vital support and resources that help people navigate life […]

Read More ›

Cure SMA to Meet with FDA for Critical Path Innovation Meeting

July 28, 2020
Posted in ,

We are excited to share with the SMA community that the U.S. Food and Drug Administration (FDA) has granted Cure SMA a Critical Path Innovation […]

Read More ›

Biogen Plans to Initiate Phase 4 Study Evaluating Benefit of Spinraza in Patients Treated with Zolgensma

July 21, 2020
Posted in ,

Biogen Inc., today announced, it plans to initiate a global Phase 4 clinical study, RESPOND, to examine the clinical benefit and assess the safety of SPINRAZA (nusinersen) […]

Read More ›

Community Spotlight: Ben Lou’s Formula for Life

June 26, 2020
Posted in ,

Ben Lou is a 17-year-old from San Diego who is fluent in both English and Chinese. He is a math whiz and fascinated by science. […]

Read More ›

Thank You for a Wonderful 2020 Virtual SMA Conference!

June 18, 2020
Posted in ,

Cure SMA would like to thank everyone who attended last week’s 2020 Virtual SMA Conference! It was an impactful week of online workshops, networking, and […]

Read More ›
Scroll to Top